Reagan-Udall Foundation For The Food And Drug Administration Inc

Learn about this cause: Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 263727917 ✦ Washington, DC ✦ Designated as a 501(c)(3)

Overview

What is Reagan-Udall Foundation For The Food And Drug Administration Inc?

The Reagan-Udall Foundation for the Food and Drug Administration Inc, based in Washington D.C., serves as a nonprofit organization with a focus on promoting innovative research and analysis within the realm of regulated products. Their primary goal is to provide data assets and analytical tools, enabling the examination of both risks and benefits associated with these products. Some of their notable initiatives include the COVID-19 Evidence Accelerator, the Innovation in Medical Evidence and Development Surveillance (IMEDS) Program, and the Algorithm Validation Studies Program. These programs are designed to modernize product development, accelerate innovation, and enhance product safety, thereby furthering the mission of the Food and Drug Administration. The Foundation currently employs 18 individuals in its mission to advance the regulatory landscape.


Official website here: www.reaganudall.org

Is Reagan-Udall Foundation For The Food And Drug Administration Inc legitimate?

Reagan-Udall Foundation For The Food And Drug Administration Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Reagan-Udall Foundation For The Food And Drug Administration Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.

Here are some key statistics you may want to consider:

Executive Compensation: $678,405
Professional Fundraising Fees: $0
Other Salaries and Wages: $1,340,019

For more financial information, click here


Official website here: www.reaganudall.org

What is the mission statement of Reagan-Udall Foundation For The Food And Drug Administration Inc?

The Reagan-Udall Foundation for the Food and Drug Administration Inc. is committed to furthering the FDA's mission by modernizing product development, spurring innovation, and enhancing product safety. Through their initiatives, they strive to provide innovative research and analysis, offering data assets and analysis tools to assess the risks and benefits of regulated products, such as the COVID-19 Evidence Accelerator, the Innovation in Medical Evidence and Development Surveillance (IMEDS) Program, and the Algorithm Validation Studies Program.


Official website here: www.reaganudall.org

Who is the CEO of Reagan-Udall Foundation For The Food And Drug Administration Inc?

Susan C Winckler Rph E is the Principal Officer of Reagan-Udall Foundation For The Food And Drug Administration Inc. The CEO's salary of Reagan-Udall Foundation For The Food And Drug Administration Inc is $406,668 and their total compensation is $439,504.


Official website here: www.reaganudall.org

What is the revenue of Reagan-Udall Foundation For The Food And Drug Administration Inc?

Reagan-Udall Foundation For The Food And Drug Administration Inc's revenue in 2022 was $8,752,229.


Official website here: www.reaganudall.org

Who are the executives of Reagan-Udall Foundation For The Food And Drug Administration Inc and what are their salaries?

The average compensation at Reagan-Udall Foundation For The Food And Drug Administration Inc during 2022 was $112,135. There are 18 employees at Reagan-Udall Foundation For The Food And Drug Administration Inc.

Here are 22 key members and their salaries (Reagan-Udall Foundation For The Food And Drug Administration Inc's CEO's salary is $406,668 and their total compensation is $439,504):

    Susan C Winckler Rph Jd (Chief Executive Officer)
  • Compensation: $406,668
  • Related: $0
  • Other: $32,836

    • Amar Bhat Phd (Chief Operating Officer)
  • Compensation: $210,482
  • Related: $0
  • Other: $28,416

    • Carla Rodriguez-Watson Phd (Director Of Research)
  • Compensation: $207,310
  • Related: $0
  • Other: $22,871

    • Lea Ann Browning-Mcnee Ma (Director Of Communications & Stakeholder Engagemen)
  • Compensation: $176,596
  • Related: $0
  • Other: $26,848

    • David Woodbury Mba (Director Of Operations)
  • Compensation: $170,613
  • Related: $0
  • Other: $27,422

    • Ellen V Sigal Phd (Chair) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Richard L Schilsky Md Facp (Fsct, Fasco, Vice Chair) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Allan Coukell Bscpharm (Secretary/Treasurer) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Helen Darling Ma (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Jonathan Leff Mba (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Adrian F Hernandez Md Mhs (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Georges C Benjamin Md Macp Fnapa (Facep(E), Hon Frsph & Ffph, Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Lynne Zydowsky Phd (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Molly Fogarty (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Andrew C Von Eschenbach Md (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Christie Boutte Pharmd Rph (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Phil Febbo Md (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • James Ek Hildreth Phd Md (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • David C Fajgenbaum Md Mba (Msc, Fcpp, Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • William N Hait Md Phd (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Debra L Ness Ms (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Edward John Allera Jd (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0


  • Official website here: www.reaganudall.org

    Where can I find the form 990 for Reagan-Udall Foundation For The Food And Drug Administration Inc?

    The Reagan-Udall Foundation For The Food And Drug Administration Inc’s most recent form 990 was submitted in 2022 and can be accessed here


    Official website here: www.reaganudall.org

    Learn more at the official website: www.reaganudall.org

    Mission Statement of Reagan-Udall Foundation For The Food And Drug Administration Inc

    The Reagan-Udall Foundation for the Food and Drug Administration Inc is a nonprofit organization dedicated to furthering the Food and Drug Administration's mission. Their primary goal is to modernize product development, stimulate innovation, and improve product safety.

    To achieve this, they engage in innovative research and analysis, providing essential data assets and analysis tools. These resources help in examining the risks and benefits associated with regulated products. Some of their notable initiatives include the COVID-19 Evidence Accelerator, the Innovation in Medical Evidence and Development Surveillance (IMEDS) Program, and the Algorithm Validation Studies Program.

    In simpler terms, the Reagan-Udall Foundation serves as a bridge between groundbreaking ideas and safe, effective products, all while ensuring the highest standards of safety and innovation are maintained.

    Impact

    This information is meant to be a general summary of Reagan-Udall Foundation For The Food And Drug Administration Inc. Please take the time to review official sources before making any decisions based upon the content provided here.




    Tuesday, June 18, 2024

    The Reagan-Udall Foundation For The Food And Drug Administration Inc is dedicated to advancing the mission of the Food and Drug Administration to modernize product development, accelerate innovation, and enhance product safety. They encourage innovative research and analysis, providing data assets and analysis tools to examine the risks and benefits of regulated products. Examples of their initiatives include the COVID-19 Evidence Accelerator, the Innovation in Medical Evidence and Development Surveillance (IMEDS) Program, and the Algorithm Validation Studies Program. Their work aims to improve the regulatory process and ultimately enhance public health and safety.





    Financials

    This financial information is from Propublica.

    Revenue
    Expenses
    Efficiency

    Other financial information:

    This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $30,611
  • Program Service Revenue: $3,614,197
  • Gross Receipts: $8,855,372

    • Assets and Liabilities:
  • Total Assets: $8,144,687
  • Total Liabilities: $4,398,051
  • Net Assets: $3,746,636
  • Programs

    Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.

    IMEDS Contract

    Revenue

    $3,614,197

    Organization Details

    Founding Year

    2009

    Principal Officer

    Susan C Winckler Rph E

    Main Address

    1333 New Hampshire Ave NW 420, Washington, DC, 20036

    NTEE Category

    Code: F01 - Mental health

    If you are a representative of Reagan-Udall Foundation For The Food And Drug Administration Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.